References – CM: an evolving technology for drug substance manufacturing

References for ‘Continuous manufacturing: an evolving technology for drug substance manufacturing’ by Matthew M. Bio. published in European Pharmaceutical Review Volume 29, Issue 3, June 2024, pp56-58. 

1. Novartis Gives M.I.T. $65 Million for Drug Development [Internet]. DealBook. 2007 [cited 2024 Jun 4]. Available from: https://archive.nytimes.com/dealbook.nytimes.com/2007/10/01/novartis-gives-mit-65-million-for-drug-development/
2. Mascia S, Heider PL, Zhang H, et al. End-to-End Continuous Manufacturing of Pharmaceuticals: Integrated Synthesis, Purification, and Final Dosage Formation. Angewandte Chemie International Edition. 2013 Oct 2;52(47):12359–63.
3. ISCMP 2014 | International Consortium for Advanced Medicines Manufacturing [Internet]. icamm.mit.edu. [cited 2024 Jun 4]. Available from: https://icamm.mit.edu/resources/iscmp-2014
4. Process Res. Dev. 2019, 38, 119-128.
5. Process Res. Dev. 2020, 24, 2043-2054.
6. Org. Chem. 2022, 87, 2045.
7. Li H, Sheeran JW, Clausen AM, et al. Flow Asymmetric Propargylation: Development of Continuous Processes for the Preparation of a Chiral β-Amino Alcohol. Angewandte Chemie International Edition. 2017 Jul 7;56(32):9425–9.
8. Phosgene Generation – Buss ChemTech AG [Internet]. www.buss-ct.com. [cited 2024 Jun 4]. Available from: https://www.buss-ct.com/phosgene_generation.html
9. For a review, see Acc. Chem. Res. 2020, 53, 1330-1341.
10. Process Res. Dev. 2021, 25, 522-528.
11. Process Res. Dev. 2022, 26, 2636-2645.
12. Process Res. Dev. 2024, 28, 831-846.
13. Chemical Engineering and Processing – Process Intensification 2021, 116, 108475.
14. Process Res. Dev. 2020, 24, 2298-2303.